Yahoo Web Search

Search results

    • Tango terminates USP1 inhibitor programme

      Tango terminates USP1 inhibitor programme

      Clinical Trials Arena via Yahoo Finance· 9 hours ago

      Tango Therapeutics has terminated the development of its TNG348 programme after data emerged from the Phase I/II trial showing that the therapy may cause...